2016
DOI: 10.1016/j.jacr.2015.07.007
|View full text |Cite
|
Sign up to set email alerts
|

2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(11 citation statements)
references
References 158 publications
0
11
0
Order By: Relevance
“…Nevertheless, standard CIEDs are not FDA‐approved for MRI imaging and carry product‐label contraindications. Furthermore, imaging is not endorsed by recent guidelines of the American College of Radiology or American College of Cardiology …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, standard CIEDs are not FDA‐approved for MRI imaging and carry product‐label contraindications. Furthermore, imaging is not endorsed by recent guidelines of the American College of Radiology or American College of Cardiology …”
Section: Discussionmentioning
confidence: 99%
“…Given safety concerns, MRI imaging in patients with cardiac electronic devices (CIEDs; i.e., pacemaker or implantable cardioverter defibrillator [ICD]) initially was absolutely contraindicated, and it continues to be not recommended for most CIED patients . For over a decade, our institution has permitted consideration of MRI in patients with nonconditional CIEDs (i.e., devices not FDA‐approved under MRI‐specified conditions).…”
Section: Introductionmentioning
confidence: 99%
“…CCTA is generally contraindicated in patients presenting with high-risk ACS and is not recommended as the first-line investigation for suspected acute SCAD. 143,147,148 Moreover, normal results on CCTA do not exclude SCAD. Coronary dissection seen on retrospective evaluation of initially negative CCTA images after SCAD was angiographically proved 149 reinforces the need for CCTA or “triple rule-out” protocols that include CCTA to be interpreted with great caution when SCAD is in the differential diagnosis as a means to minimize false-negative results.…”
Section: Diagnosismentioning
confidence: 99%
“…This choice includes weighing relative contraindications due to conditions (such as marked obesity, atrial fibrillation, extensive coronary calcification, or a patient's inability to cooperate) that degrade image quality. Case selection should incorporate the appropriate use criteria formulated collaboratively by the ACC and other organizations .…”
Section: Modality‐specific Dose Reduction Strategiesmentioning
confidence: 99%